NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Cluster 5


Climate, Energy, Mobility

In Horizon 2020 these were separate clusters but climate, energy and mobility have been merged into one to create synergies that contribute to the general goal of climate neutrality by 2050.

Your NCP contacts for this programme

Climate
Image of Fernanda Werneck

Fernanda Werneck

fernanda.werneck@vlaio.be

+32 2 550 15 65

Mobility
Image of Pascal Verheye

Pascal Verheye

pascal.verheye@vlaio.be

+32 2 432 43 34

Energy
Image of Ria De Breucker

Ria De Breucker

Ria.debreucker@vlaio.be

+32 2 553 13 77

About this programme

This cluster encompasses the transition to greenhouse gas neutrality of the energy and mobility sectors by 2050 at the latest. While most calls are about creating a more sustainable environment, there is also attention for other topics like safety in transport or digitization of the energy and mobility sector. These objectives take shape through 6 destinations:

  1. Destination 1 fosters climate science, enabling the transition to a climate-neutral and resilient society;
  2. Destination 2 supports different cross-cutting technologies and solutions for climate, energy and mobility applications;
  3. Destination 3 is about making a more sustainable, secure and competitive energy supply;
  4. Destination 4 aims to make energy use more efficient, sustainable and inclusive;
  5. Destination 5 increases the competitiveness and climate/environmental performance of different transport modes;
  6. Destination 6 advances mobility services and solutions at system level for passengers and goods.

 

As an integral part of Horizon Europe, a set of EU Missions aims to deliver solutions to some of the greatest challenges facing Europe. Notably two missions (adaptation to climate change + climate neutral and smart cities) are linked to cluster 5 as they both strive to achieve the same objective of a more climate-friendly industry and society.

The New European Bauhaus also merits to be mentioned in this respect as it focuses on a more esthetic, inclusive and sustainable way of construction.

Areas of activity

  • Climate science and solutions
  • Energy systems and grids
  • Communities and cities
  • Industrial competitiveness in transport
  • Smart mobility
  • Energy supply
  • Buildings and industrial facilities in energy transition
  • Sustainable construction
  • Clean, safe and accessible transport and mobility
  • Energy storage
Click to read more 
Hide text 

Latest news

Upcoming events

Work Programme & Calls

We offer a handy Excel file, weekly updated, containing an up-to-date overview of the Horizon Europe calls. call topics overview

Infosheets

Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.

Documents

Documents contain additional information related to this programme, and are similar to related links.

    No documents available for this domain

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.